Skip to Main Content

Paper Details

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Sci Transl Med
727
2020
COVID-19, CoV, CoV-2, Coronaviruses, EIDD-1931, EIDD-2801, MERS, MERS-CoV, NHC, SARS, SARS-CoV, SARS-CoV-2, bat-CoVs, d-N4-hydroxycytidine, host cell RNA, human, human airway epithelial cell cultures, mice, nucleoside, remdesivir, ribonucleoside
Author NameAffiliation
Amy C SimsUniversity of North Carolina at Chapel Hill
Shuntai ZhouLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Rachel L GrahamUniversity of North Carolina at Chapel Hill
Sarah R LeistUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Laura J StevensVanderbilt University Medical Center
James D ChappellVanderbilt University Medical Center
Stephanie A MontgomeryUniversity of North Carolina
Natalie J ThornburgCenters for Disease Control and Prevention
Ronald SwanstromLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Ronald SwanstromUniversity of North Carolina at Chapel Hill
Mark R DenisonVanderbilt University Medical Center
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
  • 1 - 16

Datasets

Release 1.2